Anti-atherosclerotic activity of catechins depends on their stereoisomerism

Atherosclerosis

Volumn 240, Issue 1, 2015, Pages 125-130

  Mika, Magdalena ^a   Kostogrys, Renata B ^a   Franczyk Zarów, Magdalena ^a   Wikiera, Agnieszka ^a   Maślak, Edyta ^a  

^a UNIVERSITY OF AGRICULTURE IN KRAKOW   (Poland)

Author keywords

ApoE knockout mice; Atherosclerosis; Catechins; Cholesterol

Indexed keywords

CATECHIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; ANTILIPEMIC AGENT; APOLIPOPROTEIN E; BIOLOGICAL MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG ACTIVITY; DRUG SYNTHESIS; EPIMERIZATION; LIPID DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEREOISOMERISM; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; ANALOGS AND DERIVATIVES; ANIMAL; AORTA; AORTIC DISEASES; BLOOD; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; STRUCTURE ACTIVITY RELATION;

ANIMALS; AORTA; AORTIC DISEASES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BIOMARKERS; CATECHIN; CHOLESTEROL, HDL; DISEASE MODELS, ANIMAL; HYPOLIPIDEMIC AGENTS; MALE; MICE, KNOCKOUT; MOLECULAR STRUCTURE; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRIGLYCERIDES; WEIGHT GAIN;

EID: 84924577160     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.02.026     Document Type: Article

References (30)

1. Wang H., Helliwell K. Epimerisation of catechins in green tea infusions. Food Chem. 2000, 70:337-344.
2. Mika M., Wikiera A., Zyła K. Effects of thermally modified green tea catechins on the oxidative and hydrolytic stability of butter. Health 2009, 1:192-196.
3. Xu J.Z., Yeung S.Y.V., Chang Q., Huang Y., Chen Z.Y. Comparison of antioxidant activity and bioavailability of tea epicatechins with their epimers. Br. J. Nutr. 2004, 91:873-881.
4. Del Rio D., Costa L.G., Lean M.E., Crozier A. Polyphenols and health: what compounds are involved?. Nutr. Metab. Cardiovasc. Dis. 2010, 20(1):1-6.
5. Lee S.M., Kim C.W., Kim J.K., Shin H.J., Baik J.H. GCG-rich tea catechins are effective in lowering cholesterol and triglyceride concentrations in hyperlipidemic rats. Lipids 2008, 43:419-429.
6. Onakpoya I., Spencer E., Heneghan C., Thompson M. The effect of green tea on blood pressure and lipid profile: a systematic review and meta-analysis of randomized clinical trials. Nutr. Metab. Cardiovasc. Dis. 2014, 24(8):823-836.
7. Ikeda I., Tsuda K., Suzuki Y., Kobayashi M., Unno T., Tomoyori H., Goto H., Kawata Y., Imaizumi K., Nozawa A., Kakuda T. Tea catechins with gallolyl moiety suppress postprandial hypetriacyloglycerolemia by delaying lymphatic transport of dietary fat in rats. J.Nutr. 2005, 135:155-159.
8. Ikeda I., Kobayashi M., Hamada T., Tsuda K., Goto H., Imaizumi K., Nozawa A., Sugimoto A., Kakuda T. Heat-epimerized tea catechins rich in gallocatechin gallate and catechin gallate are more effective to inhibit cholesterol absorption then tea catechins rich in epigallocatechin gallate and epicatechin gallate. J.Agric. Food Chem. 2003, 51:7303-7307.
9. Wang S., Noh S.K., Koo S.I. Green tea catechins inhibit pancreatic phospholipase A2 and intestinal absorption of lipids in ovariectomized rats. J.Nutr. Biochem. 2006, 17:492-498.
10. Annaba F., Kumar P., Dudeja A.K., Saksena S., Gill R.K., Alrefai W.A. Green tea catechin EGCG inhibits ileal apical sodium bile acid transporter ASBT. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 298:467-473.
11. Cuccioloni M., Mozzicafreddo M., Spina M., Tran C.N., Falconi M., Eleuteri A.M., Angeletti M. Epigallocatechin-3-gallate potently inhibits the invitro activity of hydroxy-3-methyl-glutaryl-CoA reductase. J.Lipid Res. 2011, 52:897-907.
12. Miura Y., Chiba T., Tomita I., Koizumi H., Miura S., Umegaki K., Hara Y., Ikeda M., Tomita T. Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J.Nutr. 2001, 131:27-32.
13. Chyu K.Y., Babbidge S.M., Zhao X., Dandillaya R., Rietveld A.G., Yano J., Dimayuga P., Cercek B., Shah P.K. Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice. Circulation 2004, 109:2448-2453.
14. Auclair S., Milenkovic D., Besson C., Chauvet S., Gueux E., Morand C., Mazur A., Scalbert A. Catechin reduces atherosclerotic lesion development in apo E-deficient mice: a transcriptomic study. Atherosclerosis 2009, 204:e21-27.
15. Norata G.D., Marchesia P., Passamontia S., Pirillo A., Violi F., Catapano A.L. Anti-inflammatory and anti-atherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice. Atherosclerosis 2007, 191:265-271.
16. Lin J.K., Lin C., Liang Y., Lin-Shiau S.-Y., Juan I.-M. Survey of catechins, gallic acid and methylxanthines in green, oolong, pu-erh and black teas. J.Agric. Food Chem. 1998, 46:3635-3642.
17. Reeves G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J.Nutr. 1993, 123:1939-1951.
18. Nicoletti A., Kaveri S., Caligiuri G., Bariety J., Hansson G.K. Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. J.Clin. Invest. 1998, 102:910-918.
19. Elhage R., Jawien J., Rudling M., Ljunggren H.G., Takeda K., Akira S., Bayard F., Hansson G.K. Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E - knockout mice. Cardiovasc. Res. 2003, 59:234-240.
20. Lee S.M., Kim C.T., Kim Y. Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice. Ann. Nutr. Metab. 2009, 54:151-157.
21. Shrestha S., Ehlers S.J., Lee J.Y., Fernandez M.L., Koo S.I. Dietary green tea extract lowers plasma and hepatic triglycerides and decreases the expression of sterol regulatory element-binding protein-1c mRNA and its responsive genes in fructose-fed, ovariectomized rats. J.Nutr. 2009, 139:640-645.
22. Mika M., Wikiera A., Zyła K. Effects of non-fermented tea extracts on invitro digestive hydrolysis of lipids and on cholesterol precipitation. Eur. Food Res. Tech. 2008, 226:731-736.
23. Yokozawa T., Nakagawa T., Kitani K. Antioxidative activity of green tea polyphenol in cholesterol-fed rats. J.Agric. Food Chem. 2002, 50:3549-3552.
24. Sutherland B.A., Shaw O.M., Clarkson A.N., Jackson D.N., Sammut I.A., Appleton I. Neuroprotective effects of (-)-epigallocatechin gallate following hypoxia-ischemia-induced brain damage: novel mechanisms of action. FASEB J. 2005, 19:258-260.
25. Lorenz M., Wessler S., Follman E., Michaelis W., Düsterhöft T., Baumann G., Stangl K., Stangl V. Aconstituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation. J.Biol. Chem. 2004, 279:6190-6195.
26. Lorenz M., Urban J., Engelhardt U., Baumann G., Stangl K., Stangl V. Green and black tea are equally potent stimuli of NO production and vasodilation: new insights into tea ingredients involved. Basic Res. Cardiol. 2009, 104:100-110.
27. Ou H.C., Song T.Y., Yeh Y.C., Huang C.Y., Yang S.F., Chiu T.H., Tsai K.L., Chen K.L., Wu Y.J., Tsai C.S., Chang L.Y., Kuo W.W., Lee S.D. EGCG protects against oxidized LDL-induced endothelial dysfunction by inhibiting LOX-1-mediated signaling. J.Appl. Physiol. 2010, 108:1745-1756.
28. Hamelet J., Demuth K., Dairou J., Ledru A., Paul J.L., Dupret J.M., Delabar J.M., Rodrigues-Lima F., Janel N. Effects of catechin on homocysteine metabolism in hyperhomocysteinemic mice. Biochem. Biophys. Res. Commun. 2007, 355:221-227.
29. Sachinidis A., Skach R.A., Seul C., Ko Y., Hescheler J., Ahn H.-Y., Fingerle J. Inhibition of the PDGF ß-receptor tyrosine phosphorylation and its downstream intracellular signal transduction pathway in rat and human vascular smooth muscle cells by different catechins. FASEB J. 2002, 16:893-895.
30. Ishii T., Minoda K., Bae M.-J., Mori T., Uekusa Y., Ichikawa T., Aihara Y., Furuta T., Wakimoto T., Kan T., Nakayama T. Binding affinity of tea catechins for HSA: characterization by high-performance affinity chromatography with immobilized albumin column. Mol. Nutr. Food Res. 2010, 54:816-822.